-
Sector Analysis
NewBusiness of Major League Baseball 2024 – Property Profile, Sponsorship and Media Landscape
Reasons to buy the ‘Business of Major League Baseball’ report: Analyze the Major League Baseball (MLB) 2024 with a clear breakdown of the commercial partnerships. Get an overview of the Baseball League social media which includes the leagues' and teams' social media breakdown. Gain insights on the League Sponsorship including Commercial Portfolio and League Sponsor Values. Examine the biggest deals of MLB 2024 and get an insightful deal analysis in terms of industry and brand location. Get an overview of...
-
Product Insights
Hyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hyaluronic Acid Fillers Pipeline Market Report Overview Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of the total HA is found in the skin. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. The hyaluronic acid fillers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the...
-
Product Insights
Likelihood of Approval Analysis for Mutational Disorders
Overview How likely is it that the drugs in Mutational Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mutational Disorders Overview Mutational disorders, alternatively termed genetic or genomic disorders, stem...
-
Product Insights
Likelihood of Approval Analysis for X Chromosome Disorders
Overview How likely is it that the drugs in X Chromosome Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. X Chromosome Disorders Overview X chromosome disorders, also termed X-linked disorders,...
-
Product Insights
Likelihood of Approval Analysis for Chromosomal Disorders
Overview How likely is it that the drugs in Chromosomal Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chromosomal Disorders Overview Chromosomal disorders arise from irregularities in chromosome structure or...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YPEG-Somatropin in Idiopathic Short Stature
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - YPEG-Somatropin in Idiopathic Short Stature report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. YPEG-Somatropin in Idiopathic Short Stature Drug Details: YPEG-somatropin is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YPEG-Somatropin in Turner Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - YPEG-Somatropin in Turner Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. YPEG-Somatropin in Turner Syndrome Drug Details: YPEG-somatropin is under development for the...
-
Company Insights
Business of the National Basketball Association (NBA) 2023-24 – Property Profile, Sponsorship and Media Landscape
Explore the following trends and insights from the ‘Business of the National Basketball Association (NBA)’ report: A comprehensive overview and expert insight into the NBA league, which is well regarded as the pinnacle of basketball globally. The sponsorship and media revenue generated for the 2023-2024 season. Break-down of the main commercial deals around each of the 30 competing teams from both a sponsorship and media perspective. Analyze the brands associated with the NBA to gain a competitive advantage. How is the...
-
Product Insights
NewTurner Syndrome – Drugs In Development, 2024
Empower your strategies with our Turner Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Turner syndrome, also referred to as congenital ovarian hypoplasia syndrome, is a chromosomal disorder that affects development in females. It results when a female's cells have one normal X chromosome and the other sex chromosome is either missing or structurally altered. About half of the population with Turner syndrome have monosomy X (45,XO). The other 50% of the population has a mosaic...